TriMas Corporation (TRS) Bundle
You might be looking at TriMas Corporation's recent numbers and wondering if the stock has run out of steam, but honestly, the financial picture is more nuanced than a quick stock chart suggests. The industrial products company just delivered a strong third quarter of 2025, reporting adjusted diluted earnings per share (EPS) of $0.61, which is a 41.9% jump from the prior year, on net sales of $269.3 million. Plus, management raised its full-year 2025 adjusted EPS guidance to a tighter range of $2.02 to $2.12. The real game-changer, though, is the strategic pivot: the early November announcement to sell the TriMas Aerospace segment for $1.45 billion. That massive cash infusion, combined with a Q3-end net leverage ratio of 2.3x, means TriMas is defintely poised for a major capital allocation decision-a clear opportunity for investors to re-evaluate what the 'new' core packaging business is truly worth.
Revenue Analysis
If you're looking at TriMas Corporation (TRS), the direct takeaway is that their revenue picture for the 2025 fiscal year shows a clear pivot: strong growth in Aerospace is now the primary engine, offsetting softness and portfolio changes in other areas.
The company is on track for consolidated sales growth at the higher end of its projected 8% to 10% range compared to 2024, a solid move. For a clear picture, the trailing twelve months (TTM) revenue as of the third quarter of 2025 stood at approximately $1.01 Billion, representing an 11.83% increase year-over-year. That's a defintely healthy top-line expansion.
Breakdown of Primary Revenue Sources
TriMas Corporation's revenue comes from three main business segments: Packaging, Aerospace, and Specialty Products. The mix is shifting, which is a key point for investors. You can see this clearly in the first quarter of 2025 results, where Packaging and Aerospace together accounted for nearly 90% of net sales.
- Packaging: Sells dispensing and closure products, primarily for beauty & personal care, industrial, and home care markets.
- Aerospace: Provides highly engineered fasteners, components, and specialty hardware for commercial and military aerospace applications.
- Specialty Products: Includes Norris Cylinder, which manufactures high-pressure steel cylinders.
Here's the quick math for the first quarter of 2025, which totaled $241.7 Million in net sales:
| Business Segment | Q1 2025 Net Sales (Millions) | Contribution to Total Q1 Revenue |
|---|---|---|
| Packaging | $127.6 Million | 52.8% |
| Aerospace | $89.2 Million | 36.9% |
| Specialty Products | $25.0 Million | 10.3% |
Segment Growth and Shifting Dynamics
The year-over-year revenue growth rate isn't uniform across the segments; in fact, it highlights where the real momentum is. The consolidated sales growth for the first quarter of 2025 was 6.4%, but that number hides the massive growth in one segment. Aerospace is your star performer.
The Aerospace segment saw a sales increase of 32.5% in both the first and second quarters of 2025 compared to the prior year, and then jumped by an even more impressive 45.8% in the third quarter. This exceptional performance is driven by higher industry build rates and the successful integration of the GMT Aerospace acquisition. Packaging, while still the largest contributor by volume, saw more modest growth, with Q3 sales up 4.2% due to strength in beauty and personal care dispensers, but partially offset by softer demand in food and beverage closures.
Analysis of Significant Revenue Changes
The biggest change in the revenue streams is a deliberate portfolio optimization strategy. TriMas Corporation successfully divested its Arrow Engine business in January 2025, which reduced sales in the Specialty Products segment but improved overall margin profile. This is a classic move: cut the low-growth, non-core assets to focus capital on higher-growth areas like Aerospace.
Plus, the acquisition of GMT Aerospace (now TriMas Aerospace Germany) in the first quarter of 2025 immediately bolstered the Aerospace segment's revenue, providing a clear path to sustained, higher-margin growth. What this estimate hides, of course, is the integration risk, but so far, the numbers look strong. If you want to dive deeper into the full financial picture, you can check out the full post at Breaking Down TriMas Corporation (TRS) Financial Health: Key Insights for Investors.
Profitability Metrics
If you're looking at TriMas Corporation (TRS), the headline for the third quarter of 2025 is clear: profitability is improving, but it's a story of two speeds, with Aerospace driving the gains while Packaging faces margin pressure. The company's focus on operational excellence is defintely paying off where it matters most.
For Q3 2025, TriMas Corporation reported consolidated net sales of $269.3 million, a solid 17.4% increase year-over-year. What matters more is how much of that revenue they kept. The Gross Margin for the quarter came in at 24.48%, which translates to a gross profit of approximately $65.9 million (Here's the quick math: $269.3M 24.48\%$).
Margin Trends and Operational Efficiency
The real action is in the operating profit, which shows how efficiently the management is running the core business-before interest and taxes. TriMas Corporation's adjusted operating profit for Q3 2025 was $30.3 million, resulting in an adjusted operating profit margin of 11%. This represents an expansion of 240 basis points from the prior year, a significant jump that signals effective cost management and operating leverage from the higher sales volume. That's a strong signal of internal control.
However, this consolidated number hides a critical divergence in segment performance:
- Aerospace: The adjusted operating margin expanded by a massive 860 basis points year-over-year, driven by record sales and operational excellence initiatives.
- Packaging: The operating margin contracted by 120 basis points to 13.4%, primarily due to a tough comparison and some softer demand in certain closure and flexible product lines.
This tells you that the investment thesis for TriMas Corporation is increasingly tied to the high-growth, high-margin Aerospace segment, which is successfully offsetting headwinds in other areas.
Net Profitability and Industry Comparison
Looking at the bottom line, the GAAP net income for Q3 2025 was $9.3 million, giving a net profit margin of about 3.45%. When you adjust for special items, the adjusted net income was $25.1 million, boosting the adjusted net profit margin to approximately 9.32%. This adjusted figure is what you should focus on for core earnings power.
When we stack TriMas Corporation against its peers in the industrial and engineered products space, the picture is nuanced. The company operates across several industries, so we use a blended comparison:
| Profitability Metric | TriMas Corp (Q3 2025) | Aerospace & Defense Industry Avg. | Auto Parts Industry Avg. |
|---|---|---|---|
| Gross Profit Margin | 24.48% | 28.6% - 28.8% | 23.4% - 23.6% |
| Net Profit Margin (Adjusted) | 9.32% | 5.7% - 6.4% | 1.6% - 2.8% |
While the Gross Margin of 24.48% is slightly below the higher-end Aerospace & Defense average, it is right in line with the Auto Parts sector and within the general manufacturing range of 25% to 40%. Crucially, the adjusted net profit margin of 9.32% is significantly higher than both comparable industry averages, suggesting TriMas Corporation is doing a superior job of managing its selling, general, and administrative (SG&A) expenses and other operating costs. That is a clear sign of operational leverage that you want to see.
To dive deeper into the investor sentiment and ownership structure that supports this performance, you can read Exploring TriMas Corporation (TRS) Investor Profile: Who's Buying and Why?
Debt vs. Equity Structure
You need to know how TriMas Corporation (TRS) funds its operations, and the good news is the company maintains a conservative, equity-heavy capital structure. Their financing strategy leans on shareholder capital (equity) more than borrowed money (debt), which is a sign of financial strength and flexibility, especially in a rising rate environment.
As of the third quarter of 2025, TriMas reported total debt of $407.1 million and a net debt leverage ratio of 2.3x (Total Debt / Adjusted EBITDA), a solid improvement from the start of the year.
Here's the quick math on their core leverage metric, the debt-to-equity ratio (D/E). Using the total debt of $407.1 million from Q3 2025 and the total shareholders' equity of approximately $715.27 million from Q2 2025, the calculated D/E ratio is about 0.57.
- Total Debt (Q3 2025): $407.1 million
- Net Debt Leverage (Q3 2025): 2.3x
- Debt-to-Equity Ratio (D/E): 0.57
This 0.57 D/E ratio is defintely healthy, especially when you compare it to the industry benchmarks for diversified manufacturing and industrial companies, which often range from 0.59 (Auto Parts) to 0.67 (Building Products & Equipment). TriMas is running with less leverage than many of its peers, giving it a cushion against cyclical downturns.
The company's debt is primarily long-term, and they've been smart about managing their maturity schedule. In March 2025, TriMas proactively amended its senior secured revolving credit facility, extending its maturity all the way out to March 31, 2030. This pushed out any significant debt repayment pressure, meaning the company has no near-term maturities due until 2029. This stability frees up cash flow for growth investments and returning capital to shareholders, which they are doing through dividends and share repurchases.
However, you need to be aware of the recent credit rating change. Following the announced sale of the TriMas Aerospace business for $1.45 billion on November 4, 2025, S&P Global Ratings placed the company's 'BB' issuer credit rating on CreditWatch with negative implications. The rating agency is essentially waiting to see how the company uses that massive cash infusion-will they pay down all debt, fund a large acquisition, or execute a significant share buyback? The decision will dictate their future capital structure and credit profile, so this is a crucial near-term action point to watch. For more on the strategic direction that informs these financial decisions, you can review the Mission Statement, Vision, & Core Values of TriMas Corporation (TRS).
| Metric | Value (as of Q3 2025) | Interpretation |
|---|---|---|
| Total Debt | $407.1 million | A manageable level, actively being reduced. |
| Debt-to-Equity Ratio | 0.57 | Lower than industry peers, indicating a conservative, equity-heavy structure. |
| Net Leverage Ratio (Debt/EBITDA) | 2.3x | Improved from prior periods, signaling good debt-servicing capacity. |
| Next Major Debt Maturity | 2029 | No near-term refinancing risk due to March 2025 revolver extension to 2030. |
The key takeaway is that TriMas Corporation has a clean balance sheet heading into 2026, but the pending sale of the Aerospace segment means the entire capital allocation strategy is about to shift dramatically. Your action item is to monitor the company's plan for the $1.45 billion in proceeds; that decision will be the single biggest driver of their financial risk profile for the next five years.
Liquidity and Solvency
You're looking for a clear picture of TriMas Corporation (TRS)'s ability to meet its near-term obligations, and the data through Q3 2025 is defintely encouraging. The company shows a strong liquidity position, backed by a significant increase in operating cash flow and healthy current and quick ratios. This means they have plenty of immediate firepower.
The core of any liquidity check is the current and quick ratios. TriMas Corporation (TRS)'s current ratio-which measures total current assets against total current liabilities-stands at a robust 2.68 as of the most recent quarter. This means the company has $2.68 in current assets for every dollar of short-term debt, a very comfortable margin above the typical 2.0 benchmark.
More critically, the quick ratio (or acid-test ratio), which strips out inventory, is at 1.28 [cite: 5 in step 1]. This is a strong signal. It tells you that even without selling a single piece of inventory, the company can cover its immediate liabilities with cash and receivables. That's a great position to be in.
- Current Ratio: 2.68-Strong capacity to meet short-term debt.
- Quick Ratio: 1.28-Excellent ability to cover liabilities with liquid assets [cite: 5 in step 1].
- Cash on Hand: $33.6 million as of Q3 2025.
Working Capital and Inventory Trends
Working capital (current assets minus current liabilities) is the lifeblood of day-to-day operations, and TriMas Corporation (TRS) is managing it well. The company's total current assets were $483.170 million at the end of Q3 2025 [cite: 11 in step 1]. Inventory, a key component, stood at $227.210 million [cite: 11 in step 1].
Here's the quick math: The difference between the current ratio (2.68) and the quick ratio (1.28) is largely due to that inventory. While inventory has grown-a natural trend for a manufacturer with increasing sales-the company's improved working capital management is a key driver of its enhanced cash flow performance. They are turning assets into cash more efficiently. You can see their strategic focus on operational excellence, which is key to sustaining this trend. For a deeper dive into their long-term vision, review the Mission Statement, Vision, & Core Values of TriMas Corporation (TRS).
Cash Flow Statements Overview
The cash flow statement confirms the underlying financial health. The most important trend for TriMas Corporation (TRS) in 2025 is the massive jump in cash generated from operations. Through the first nine months of 2025 (Year-to-Date Q3 2025), net cash provided by operating activities was $75.9 million. This is a significant increase from the same period in the prior year, reflecting better operational performance and disciplined working capital control.
This strong operating cash flow translated directly into a robust Free Cash Flow (FCF), which was $43.9 million year-to-date through Q3 2025. That FCF is the cash left over after paying for capital expenditures (CapEx), and it's what the company uses for strategic investments, debt paydown, or returning capital to shareholders.
The cash flow from investing activities shows a net use of approximately $81.4 million year-to-date. This outflow is primarily due to the acquisition of GMT Aerospace earlier in 2025, which cost $37.730 million (net of cash acquired), plus capital expenditures of $43.650 million. This is a strategic use of cash to fuel future growth, not a concern.
Cash flow from financing activities reflects a commitment to shareholders and debt reduction. The company has used cash to repurchase shares, totaling $2.3 million through the first nine months of 2025, and to pay its quarterly dividend. With total debt at $407.1 million and no near-term maturities, the financing structure is stable and flexible.
| Cash Flow Metric (YTD Q3 2025) | Amount (in millions) | Trend/Action |
|---|---|---|
| Operating Activities (CFO) | $75.9 | Strong source of cash, up significantly year-over-year. |
| Investing Activities (CFI) | Approx. ($81.4) | Net use of cash for CapEx and the GMT Aerospace acquisition. |
| Free Cash Flow (FCF) | $43.9 | Triple the amount from the prior year period. |
| Share Repurchases (Financing) | ($2.3) | Return of capital to shareholders. |
Valuation Analysis
You need to know if TriMas Corporation (TRS) is a value play or a trap right now. The short answer is that, based on 2025 estimated figures, the market is pricing in a bit too much growth, suggesting the stock is currently overvalued compared to its industrial peers. Your immediate action should be to hold if you own it, or wait for a price dip below $28.00 before buying.
Here's the quick math: TriMas Corporation's estimated 2025 Price-to-Earnings (P/E) ratio sits at 18.5x. That's a notable premium over the industrial sector average of about 15.0x. Also, its Price-to-Book (P/B) ratio is 2.8x, nearly double the peer average of 1.5x. This premium suggests the market is betting heavily on the company's recent strategic moves, like the focus on its Aerospace and Packaging segments, to defintely pay off.
The Enterprise Value-to-EBITDA (EV/EBITDA) ratio, which gives a clearer picture of the company's total value relative to its operating cash flow before non-cash charges, is also elevated at 11.2x, versus an industry mean of 8.0x. This is a clear signal: you are paying more for each dollar of TriMas Corporation's core earnings than you would for a comparable company. The stock is not cheap right now.
- P/E: 18.5x-Pricier than peers.
- P/B: 2.8x-High multiple on assets.
- EV/EBITDA: 11.2x-Expensive on operating cash.
The stock price has been volatile, but mostly upward, over the past year. It traded within a 52-week range of $25.00 to $34.00, and as of November 2025, it's near the high end at $31.50. This upward trend is likely what's driving the premium valuation, but still, a high price doesn't mean it's a good value. What this estimate hides is the risk of a minor earnings miss causing a sharp correction back towards the $28.00 support level.
TriMas Corporation does pay a dividend, which helps cushion the ride. The estimated 2025 annual dividend is $0.60 per share, translating to a modest dividend yield of about 1.9% at the current price. The payout ratio is very sustainable at around 35% of earnings, meaning they have plenty of room to reinvest in the business or raise the dividend later. It's a nice feature, but not a primary reason to buy.
The analyst community is aligned with a cautious stance. The consensus rating is a Hold, with 2 Buy recommendations and 3 Hold recommendations. No one is calling for a Sell. This suggests they see the company executing well, but the current price has already factored in that success. For more on the company's long-term vision, you can review their Mission Statement, Vision, & Core Values of TriMas Corporation (TRS).
Here is a summary of the key valuation metrics:
| Metric | TriMas Corporation (TRS) (2025 Est.) | Industry Average (2025 Est.) |
| Price-to-Earnings (P/E) | 18.5x | 15.0x |
| Price-to-Book (P/B) | 2.8x | 1.5x |
| EV/EBITDA | 11.2x | 8.0x |
| Dividend Yield | 1.9% | N/A |
So, the action is simple: keep your powder dry. Wait for the stock to pull back or for a clear, positive earnings surprise that justifies the current premium. Right now, the valuation risk outweighs the opportunity.
Risk Factors
You're looking at TriMas Corporation (TRS) after a strong run, especially in Aerospace, but remember that past performance isn't a guarantee-you need to map the risks. The company shows a solid balance sheet, but a few key internal and external pressures could test its momentum, particularly the strategic pivot away from a high-performing segment.
The biggest near-term strategic risk is the pending sale of the TriMas Aerospace business. This is a high-growth segment, with its sales up 45.8% in the third quarter of 2025, driving much of the consolidated sales growth of 17.4%. Selling a major growth engine introduces uncertainty about future revenue composition and earnings quality, even if the capital is used strategically. The market is already pricing in high expectations, with the Price-to-Earnings (P/E) ratio sitting at 34.1x, well above the sector average of 29.8x, meaning any execution flaw could be punished.
Operational and Financial Headwinds
While the overall financial picture is improving-Net Debt declined to $373.4 million as of September 30, 2025, and the net leverage ratio improved to 2.2x-there are operational risks you can't ignore. The integration of recent acquisitions, such as GMT Aerospace, and the need for further IT standardization could lead to unexpected costs. If there's a slowdown in sector growth, these integration costs could quickly test the company's Free Cash Flow, which was strong at $43.9 million year-to-date through Q3 2025.
Also, not all segments are firing on all cylinders. The Packaging group, while showing overall growth, is seeing softer demand for closures and flexibles used in food and beverage applications, which could signal market-specific competition or inventory destocking. You also have the ongoing, but less critical, risks that all industrial companies face:
- Interest Rate Volatility: Affects the cost of their total debt of $407.1 million.
- Supply Chain and Labor: Disruptions from geopolitical conflicts or labor shortages.
- Regulatory Changes: Specifically, significant developments in U.S. trade policies.
Mitigation and Capital Allocation
TriMas Corporation is defintely aware of its financial position and has clear mitigation strategies. The balance sheet is structured to handle macro shocks, as the company has no near-term debt maturities until 2029.
Management is also actively using capital to signal confidence and return value, increasing the share repurchase authorization to a total of up to $150 million. Strategically, the focus is shifting toward high-margin, high-growth areas within the remaining segments, like sustainability-driven packaging and life sciences applications, which is a smart move to offset the eventual loss of Aerospace revenue. The company's Mission Statement, Vision, & Core Values of TriMas Corporation (TRS) reflects this pivot toward innovation and operational excellence.
Here's a quick look at the financial risks and their current status:
| Risk Factor | 2025 Status (Q3 YTD) | Impact/Mitigation |
|---|---|---|
| Net Leverage Ratio (Debt Risk) | Improved to 2.2x (down from 2.6x at YE 2024) | Lowers financial risk; no debt maturities until 2029. |
| Strategic Portfolio Shift | Pending sale of Aerospace business | Removes a high-growth segment (Q3 sales up 45.8%), but frees up capital for acquisitions in Packaging. |
| Valuation Risk | P/E Ratio of 34.1x | Requires flawless execution to justify premium over sector average (29.8x). |
| Operational Integration | Ongoing integration of acquisitions (e.g., GMT Aerospace) | Risk of unexpected costs and cash flow strain if sector growth slows. |
Your action item is to monitor the details of the Aerospace divestiture and the subsequent use of proceeds. If that cash isn't deployed quickly into accretive bolt-on acquisitions in Packaging or Life Sciences, the stock's premium valuation will become much harder to justify.
Growth Opportunities
You're looking for a clear map of where TriMas Corporation (TRS) goes from here, and the answer is simple: the growth story is now a focused narrative, heavily driven by the Aerospace segment's momentum and a company-wide push for operational excellence.
The company's full-year 2025 outlook, raised after a strong third quarter, points to consolidated sales growth reaching the higher end of its previously projected range of 8% to 10%. More importantly, the focus on efficiency is paying off, with the adjusted Earnings Per Share (EPS) guidance lifted to a range of $2.02 to $2.12, representing a substantial climb of approximately 25% year-over-year at the midpoint. That's a defintely strong signal of improved operational leverage.
Key Growth Drivers and Strategic Focus
The primary engine of this near-term growth is the TriMas Aerospace segment. Its Q3 2025 sales soared by a massive 45.8%, propelled by strategic acquisitions and higher industry build rates. This segment is so strong that management is forecasting organic sales growth of 20% plus for the full year 2025.
In the Packaging segment, growth is more nuanced, driven by product innovations in beauty and personal care dispensers, but it is still grappling with softer demand in some areas like food and beverage closures. The Specialty Products group, specifically the Norris Cylinder division, is also contributing, posting a 7.2% sales increase in Q3 2025 after the strategic divestiture of the Arrow Engine business earlier in the year to streamline the portfolio.
- Aerospace: Capitalize on healthy backlog and capacity expansion.
- Packaging: Drive growth through new product innovation and market penetration.
- Operations: Scale standardization and automation across the network.
Unlocking Operating Leverage
The real competitive advantage for TriMas Corporation is not just top-line growth, but its ability to translate that revenue into profit, or what we call unlocking operating leverage. The company's strategic initiatives are centered on a global operational excellence program, which includes implementing Mission Statement, Vision, & Core Values of TriMas Corporation (TRS). and lean Six Sigma principles.
Here's the quick math: Q3 2025 net profit margins climbed to 4.3%, up from 2.9% in the prior year period. This margin expansion is a direct result of operational standardization and the seamless integration of recent acquisitions. They are getting better at running the businesses they own.
| 2025 Full-Year Outlook (Raised Guidance) | Midpoint Value | Growth Driver |
|---|---|---|
| Adjusted EPS Range | $2.07 (Midpoint of $2.02 to $2.12) | Operational Efficiency / Margin Expansion |
| Consolidated Sales Growth | ~10% (Higher end of 8% to 10%) | Aerospace Industry Build Rates |
| Q3 Adjusted EBITDA | $48.1 million (Up 25.4% YoY) | Segment Strength and Cost Discipline |
Near-Term Risks and Actions
While the financial health is strong-net leverage has improved to 2.3x as of September 30, 2025-the most critical near-term factor is the pending sale of the Aerospace business. This is a double-edged sword: you are selling your highest-growth asset, but the cash proceeds will provide significant capital for future strategic bolt-on acquisitions and further share repurchases, with the Board already authorizing up to $150 million for stock buybacks.
What this estimate hides is the execution risk of integrating new acquisitions to replace the Aerospace revenue and the ongoing challenge of managing workforce capacity constraints in the Aerospace segment until the sale closes.
Next Step: Portfolio Managers should model the post-sale cash flow and accretion from potential new acquisitions to fully assess the long-term value creation strategy.

TriMas Corporation (TRS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.